Lyophilized Injectable Market Predicted to Reach USD 5 billion by 2031, Registering at a 5% CAGR | Exclusive Report by Transparency Market Research

The global market for lyophilized injectables is expected to see a paradigm shift as a result of embedded technological features in devices and injectors.


Wilmington, Delaware, United States, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global market for lyophilized injectable is anticipated to advance with almost a 5% CAGR from 2021 to 2031 and by 2031; the market is likely to gain US$ 5 billion.

When a substance is unstable in aqueous solution, the most often utilized procedure for producing parenteral pharmaceutical products is lyophilization. It is crucial to the preservation of materials that require a sterile and delicate preservation technique and low moisture content (less than 1%) to maintain stability.

Get Sample PDF Copy at: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=82201

Global Lyophilized Injectable Market: Key Players

Major companies are becoming increasingly interested in developing universal, upgradeable, and flexible drug delivery systems to meet the growing need for lyophilized injectables on a global basis. They are investing a sizable sum of money in activities connected to research and development to accomplish this.

The following companies are well-known participants in the global lyophilized injectable market:

  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • BD
  • Schott AG
  • Aristopharma Ltd.
  • Vetter Pharma
  • Jubilant HollisterStier LLC

Developments by the key players in the global market for lyophilized injectable are:

Market PlayerYearKey Developments
Recipharm2022
  • Arranta Bio, a CDMO (Contract Development and Manufacturing Organization) for advanced treatment, and Vibalogics, a CDMO for virotherapy, were both acquired by Recipharm.
  • Recipharm now has a strong footing in the USA and a solid basis upon which to develop its capabilities into additional biologics modalities due to its new facilities in Boxborough, Massachusetts as a consequence of the acquisition.
Bristol Myers Squibb2022
  • The company to achieve a portfolio of various experimental medicines acquired Turning Point Therapeutics.
  • These medicines were used to target oncogenic mutations.

Industry professionals are implementing lyophilization in their manufacturing processes due to the improved quality and shelf life of lyophilized medications. Lyophilized injectable pharmaceuticals are being more often used by contract research and manufacturing companies to deliver high-quality goods to consumers.

Key Findings of the Market Report

  • The Asia Pacific lyophilized injectable market is predicted to expand rapidly in the next years as a result of unexplored potential, improved healthcare infrastructure, and increased availability of contract manufacturing as well as research services.
  • Compared to non-lyophilized items, lyophilized products are thought to be safe to use while providing the intended functionality.
  • Global demand for lyophilized injectables is anticipated to be driven by CRAMS, a rapidly expanding industry.

Market Trends for Lyophilized Injectable

  • Injectable drugs that have been lyophilized are stable at room temperature and just need to be rehydrated before use. This streamlines and simplifies procedures while removing several potential causes of pipetting problems.
  • Eliminating the cold chain reduces costs and carbon footprint while also having a beneficial environmental impact by reducing the demand for expanded polystyrene (EPS or 'Styrofoam') containers. These are commonly used to export temperature-controlled items.
  • Compared to non-lyophilized items, lyophilized products are thought to be safe to use while providing the intended functionality. Lyophilization aids in keeping the chemical compound's biological and chemical activity present in the finished product. This fuels the pharmaceutical and biotechnology sectors' need for lyophilized injectable drugs.

Get Exclusive Discount on Lyophilized Injectable Market at: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=82201

Lyophilized Injectable Regional Market Outlook

Various reasons are propelling the growth of the lyophilized injectable market in different regions. These are:

  • In North America, the lyophilized injectable market was dominated by the United States in 2019. The region is expected to dominate the worldwide market during the forecast period due to the rise in the prevalence of chronic illnesses and the increasing acceptance of lyophilized injectable pharmaceuticals in the area's nations.
  • From 2018 to 2026, the lyophilized injectables market in Asia Pacific is predicted to grow at an impressive CAGR. The area includes developing nations including Malaysia, Thailand, Singapore, China, Indonesia, and India. Asia Pacific, which was the third-largest market in the world in 2017, has substantial prospects in the healthcare industry. Large prospects exist for these type of injectables in these nations for the healthcare industry.

Global Lyophilized Injectable Market Segmentation

Type of Packaging
  • Single-use Vials
  • Point-of-care Reconstitution
  • Specialty Packaging
Type of Delivery
  • Prefilled Diluent Syringes
  • Proprietary Reconstitution Devices
  • Single-step Devices
  • Multi-step Devices
Indication
  • Autoimmune Diseases
  • Infectious Diseases
  • Metabolic Conditions
  • Others
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Place an Order Copy of Lyophilized Injectable Market Report at:    https://www.transparencymarketresearch.com/checkout.php?rep_id=82201&ltype=S

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com   
Blog: https://tmrblog.com   

Email: sales@transparencymarketresearch.com